From June 3 to 7, 2022, we will be setting up our quarters in Chicago for the American Society of Clinical Oncology Annual Meeting to continue gaining the latest insights in research and clinical development in Oncology. Also, our CEO Dr. Alban Bessede will have the great opportunity to present a scientific poster highlighting our recent advances in biomarker research in Immuno-Oncology.

We are eager to meet you there, discuss your research projects and introduce our service offerings to support your drug discovery programs.


2596 –
Identification of super-exhausted T cells: A novel population predictive of response to immunotherapyPeyraud et al.

Presenter: Alban Bessede

Sunday, June 5, 2022 / 8:00 AM – 11:00 AM / Hall A

Developmental Therapeutics – Immunotherapy


Leave a Reply

Your email address will not be published.

This field is required.

You may use these <abbr title="HyperText Markup Language">html</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This field is required.

WordPress Lightbox